How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and successfully differentiate it against their closest competitor.Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. As a result, our client wanted to understand in detail the impact of their data on physicians’ perceptions of them.
Procedure Immersion: How we unlocked hidden insights using a visual roadmap to simulate the OR experience
Often the precision behind the use of a device during a procedure is lost when Surgeons speak to laymen, even skilled medical moderators.
The client challenged us to find a way to bring more precision into the discussion, and to ensure that all the procedural steps were mapped
How we supported the integration of a new specialty pharmacy product into physician offices
Our client was launching a novel device and needed to understand the potential drivers and barriers to practice integration. The client requested a detailed journey map, identifying areas of challenge or gaps from different clinical, as well as administrative and purchasing perspectives
How we assessed the opportunity for a rare disease product in emerging markets
Our client had a product indicated for a rare Haematology disease. Whilst this product was successfully launched in over 40 countries globally, it had a limited presence in many emerging markets. Our client needed to conduct market research in order to determine how to maximise the commercial opportunities in each of these different emerging markets.
How we evaluated the potential for an existing AI product to treat a rare disease
Our client had an existing product in the market for the treatment of an autoimmune condition and wished to explore the opportunities for using this drug to treat another more low-prevalence orphan disease where there is no current targeted treatment available. The client wished to determine the market potential for the existing drug and the challenges they may face.